Copying and distributing are prohibited without permission of the publisher.

Watermark

SK Biopharma pockets W959bn from IPO

Pharma_drugs_adobe_575x375.jpg
By Jonathan Breen
22 Jun 2020

Drug developer SK Biopharmaceuticals priced its IPO high last Friday, netting W959.3bn ($792m), according to a source close to the deal.

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
By Jonathan Breen
22 Jun 2020